| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Third Department of Internal Medicine, Faculty of Medicine University of Tokyo, Hongo, Tokyo, Japan
Reprint requests should be sent to Dr. Shigenobu Nagataki.
Studies were performed on 40 patients with severe primary hypothyroidism, during treatment with varying doses of T4. Therapy was initiated with 50 µg/day and was continued for at least 2 months. Subsequent repeated increases of 25 µg/day were continued for at least 2 months until the serum TSH level was <10 µU/ml. Measurements of serum T4 and T3, RT3U, and serum TSH were carried out at monthly intervals. TRH tests were performed after TSH levels of <10 /U/ml had been attained and the dose of T4 had been maintained for at least 2 months. In most of the samples obtained during treatment with various doses of T4 (50–175 µg/day), serum T4 concentrations were within the normal range, even when patients were receiving only 50 µg/day of T4; however, approximately 60% of the samples had subnormal T3 concentrations. Fifty per cent of the samples had elevated TSH concentrations despite normal T4 levels, while only 7% of the samples with normal T3, as well as T4, levels had slightly elevated TSH concentrations. Similar relationships were observed between serum TSH and free T4 indices and free T3 indices. Among patients with serum TSH levels of <10 µU/ml, none showed subnormal T4 concentrations, while subnormal T3 concentrations were found in some of them. Hyper-response to TRH was noted in patients with subnormal T3 levels, and normal responses were observed in patients with normal T3 and T4 concentrations. These data indicate that, during the treatment of hypothyroidism with T4, 1) normal basal TSH correlates better with normal serum T4 and T3 than with normal T4 alone, 2) the response of TSH to TRH is supranormal in patients with subnormal T3 levels, in spite of normal basal TSH and T4, and 3) the calculated maintenance dose of T4, which is associated with a normal TRH response, is 2.08 µg/day/kg of body weight.
This work was supported in part by the Research Grant for Specific Disease (Hashimoto's disease) from the Ministry of Health and Welfare, Japan.
Presented in part at the 57th Annual Meeting of American Endocrine Society in New York, 1975.
1 Present address: Department of Internal Medicine, Tokyo Women's Medical College, Kawada-cho, Shinjuku-ku, Tokyo.
2 Present address: Department of Medicine, Beth Israel Hospital, Boston, Mass.
3 Present address: Department of Internal Medicine, School of Medicine, University of California Davis, Davis, California.
Received August 7, 1975.
This article has been cited by other articles:
 |
|
 |
|
  M. Helfand and L. M. Crapo Monitoring Therapy in Patients Taking Levothyroxine Ann Intern Med, September 15, 1990; 113(6): 450 - 454. [Abstract] [PDF]
|
|
|
|
|
|
J. V. HENNESSEY, J. E. EVAUL, Y.-C. TSENG, K. D. BURMAN, and L. WARTOFSKY L-Thyroxine Dosage: A Reevaluation of Therapy with Contemporary Preparations Ann Intern Med, July 1, 1986; 105(1): 11 - 15. [Abstract] [PDF]
|
|
|
|
 |
|
 F. B. Davis, R. S. LaMantia, S. W. Spaulding, R. E. Wehmann, and P. J. Davis Estimation of a Physiologic Replacement Dose of Levothyroxine in Elderly Patients With Hypothyroidism Arch Intern Med, September 1, 1984; 144(9): 1752 - 1754. [Abstract] [PDF]
|
|
|
|
|
|
D. Salmon, M. Rendell, J. Williams, C. Smith, D. A. Ross, J. M. Waud, and J. E. Howard 'Chemical Hyperthyroidism' Serum Triiodothyronine Levels in Clinically Euthyroid Individuals Treated With Levothyroxine Arch Intern Med, March 1, 1982; 142(3): 571 - 573. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Bunner Organic Medicine: Thyroid Hormone Replacement Therapy, 1891-1977 Arch Intern Med, June 1, 1978; 138(6): 978 - 979. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
